True Metric Labs
Not for sale yet
Joints First
Nothing for sale yet. That is the point.
45–65. Knees, hips, or shoulders have been loud for years.
Surgery is not the plan unless it has to be.
You tried the aisle, the fads, the longevity stack. You still want an ordinary Tuesday back.
We only sell ingredients at the dose the evidence actually used. If we can’t print that dose, we don’t make the bottle.
Why These Two
Two actives. Disclosed doses. No blend. We did not invent a new stack — we used the amounts the knee trials actually ran.
Aflapin / AprèsFlex — 100 mg/day
Karlapudi et al., 2023 · Knee osteoarthritis · ~30 days · 67 people finished
In the Aflapin group, VAS pain scores were ~45% lower than baseline at day 30. Some scores moved by day 5.
Sponsor-linked study. We print the dose they used: 100 mg.
This is the ingredient trial. It is not a trial of our bottle.
Theracurmin — ~180 mg curcumin/day
Nakagawa et al., 2014 · Knee osteoarthritis · 8 weeks
Pain VAS was lower versus placebo in people who started with more than trivial pain. They also used less celecoxib.
Modest. We print the dose they used: ~180 mg curcumin.
This is the ingredient trial. It is not a trial of our bottle.
What We Will Not Say
We will not say “users of True Metric saw X.”
We will not put a week-count on your knees.
We will not check out until the formula is locked.
Every claim above is bound by the standard. There is no checkout. That is the point.